ISOMORPHIC LABORATORIES Trademark

Trademark Overview


On Monday, December 13, 2021, a trademark application was filed for ISOMORPHIC LABORATORIES with the United States Patent and Trademark Office. The USPTO has given the ISOMORPHIC LABORATORIES trademark a serial number of 97170047. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, May 17, 2024. This trademark is owned by Isomorphic Labs Limited. The ISOMORPHIC LABORATORIES trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:

Downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; downloadable computer software, computer programs and computer software algorithms for manipulating received or inputted data generated in a virtual space in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development

Software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online, non-downloadable computer software platforms using artif...
isomorphic laboratories

General Information


Serial Number97170047
Word MarkISOMORPHIC LABORATORIES
Filing DateMonday, December 13, 2021
Status730 - FIRST EXTENSION - GRANTED
Status DateFriday, May 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 26, 2023

Trademark Statements


Goods and ServicesDownloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; downloadable computer software, computer programs and computer software algorithms for manipulating received or inputted data generated in a virtual space in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development
NOT AVAILABLE"LABORATORIES"
Goods and ServicesSoftware as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online, non-downloadable computer software platforms using artificial intelligence, machine earning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; testing of computing methods, computer software algorithms, computer software, and computer hardware for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific research in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer aided data analysis for scientific research purposes in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, data tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, chemistry, physics, biology, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateFriday, December 17, 2021
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 17, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIsomorphic Labs Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon EC2M4RB
GB

Party NameIsomorphic Labs Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon EC4V6JA
GB

Trademark Events


Event DateEvent Description
Thursday, December 16, 2021NEW APPLICATION ENTERED
Friday, December 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 20, 2022ASSIGNED TO EXAMINER
Wednesday, September 21, 2022NON-FINAL ACTION WRITTEN
Wednesday, September 21, 2022NON-FINAL ACTION E-MAILED
Wednesday, September 21, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 3, 2023ASSIGNED TO EXAMINER
Thursday, May 25, 2023FINAL REFUSAL WRITTEN
Thursday, May 25, 2023FINAL REFUSAL E-MAILED
Thursday, May 25, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, August 14, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, August 14, 2023EXAMINERS AMENDMENT E-MAILED
Monday, August 14, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 14, 2023EXAMINER'S AMENDMENT ENTERED
Monday, August 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 18, 2023ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, August 21, 2023ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, September 6, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 26, 2023PUBLISHED FOR OPPOSITION
Tuesday, September 26, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, May 17, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 17, 2024SOU EXTENSION 1 FILED
Friday, May 17, 2024SOU EXTENSION 1 GRANTED
Tuesday, November 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, April 19, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 19, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 19, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED